321 related articles for article (PubMed ID: 18387477)
1. Neoadjuvant chemotherapy in invasive breast cancer results in a lower axillary lymph node count.
Bélanger J; Soucy G; Sidéris L; Leblanc G; Drolet P; Mitchell A; Leclerc YE; Beaudet J; Dufresne MP; Dubé P
J Am Coll Surg; 2008 Apr; 206(4):704-8. PubMed ID: 18387477
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting lymph node yield in patients undergoing axillary node dissection for primary breast cancer: a single-institution review.
Lee MC; Plews R; Rawal B; Kiluk JV; Loftus L; Laronga C
Ann Surg Oncol; 2012 Jun; 19(6):1818-24. PubMed ID: 22203185
[TBL] [Abstract][Full Text] [Related]
4. Number of lymph nodes identified at axillary dissection: effect of neoadjuvant chemotherapy and other factors.
Boughey JC; Donohue JH; Jakub JW; Lohse CM; Degnim AC
Cancer; 2010 Jul; 116(14):3322-9. PubMed ID: 20564124
[TBL] [Abstract][Full Text] [Related]
5. Factors predictive of having four or more positive axillary lymph nodes in patients with positive sentinel lymph nodes: implications for selection of radiation fields.
Shahar KH; Hunt KK; Thames HD; Ross MI; Perkins GH; Kuerer HM; Strom EA; McNeese MD; Meric F; Schechter NR; Sahin AA; Middleton LP; Buchholz TA
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1074-9. PubMed ID: 15234041
[TBL] [Abstract][Full Text] [Related]
6. Axillary staging prior to or after neoadjuvant systemic therapy? A single institutional experience.
Al Mushawah F; Tan MC; Margenthaler JA
J Surg Oncol; 2010 Oct; 102(5):404-7. PubMed ID: 20082352
[TBL] [Abstract][Full Text] [Related]
7. The impact of axillary lymph nodes removed in staging of node-positive breast carcinoma.
Kuru B; Bozgul M
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1328-34. PubMed ID: 16997505
[TBL] [Abstract][Full Text] [Related]
8. [Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer].
Mátrai Z; Tóth L; Polgár C; Láng I; Gõdény M; Sinkovics I; Horváth Z; Bidlek M; Udvarhelyi N; Bartal A; Sávolt A; Ujhelyi M; Kásler M
Magy Onkol; 2011 Jun; 55(2):73-84. PubMed ID: 21655472
[TBL] [Abstract][Full Text] [Related]
9. Lower nodal counts in axillary dissection following neoadjuvant chemotherapy: are there implications?
Callcut RA; Breslin TM
Am J Surg; 2006 Jun; 191(6):830-1. PubMed ID: 16720160
[No Abstract] [Full Text] [Related]
10. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
11. Breast sentinel lymph node dissection before preoperative chemotherapy.
Grube BJ; Christy CJ; Black D; Martel M; Harris L; Weidhaas J; Digiovanna MP; Chung G; Abu-Khalaf MM; Miller KD; Higgins SA; Philpotts L; Tavassoli FA; Lannin DR
Arch Surg; 2008 Jul; 143(7):692-9; discussion 699-700. PubMed ID: 18645113
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation.
Lang JE; Esserman LJ; Ewing CA; Rugo HS; Lane KT; Leong SP; Hwang ES
J Am Coll Surg; 2004 Dec; 199(6):856-62. PubMed ID: 15555967
[TBL] [Abstract][Full Text] [Related]
13. Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients.
Lee S; Kim EY; Kang SH; Kim SW; Kim SK; Kang KW; Kwon Y; Shin KH; Kang HS; Ro J; Lee ES
Breast Cancer Res Treat; 2007 May; 102(3):283-8. PubMed ID: 17063280
[TBL] [Abstract][Full Text] [Related]
14. Accurate axillary nodal staging can be achieved after neoadjuvant therapy for locally advanced breast cancer.
Patel NA; Piper G; Patel JA; Malay MB; Julian TB
Am Surg; 2004 Aug; 70(8):696-9; discussion 699-700. PubMed ID: 15328803
[TBL] [Abstract][Full Text] [Related]
15. Drug concentrations in axillary lymph nodes after lymphatic chemotherapy on patients with breast cancer.
Chen J; Wang L; Yao Q; Ling R; Li K; Wang H
Breast Cancer Res; 2004; 6(4):R474-7. PubMed ID: 15217515
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy after neoadjuvant systemic chemotherapy in patients with breast cancer: a prospective pilot trial.
Medina-Franco H; Salgado-Nesme N; Zerón-Medina-Cuairán J
Rev Invest Clin; 2008; 60(5):390-4. PubMed ID: 19227436
[TBL] [Abstract][Full Text] [Related]
17. Touch imprint cytology of axillary lymph nodes after neoadjuvant chemotherapy in patients with breast carcinoma.
Jain P; Kumar R; Anand M; Asthana S; Deo SV; Gupta R; Bhutani M; Karak AK; Shukla NK
Cancer; 2003 Dec; 99(6):346-51. PubMed ID: 14681942
[TBL] [Abstract][Full Text] [Related]
18. Breast conservation after neoadjuvant chemotherapy for stage II carcinoma of the breast.
Schwartz GF; Meltzer AJ; Lucarelli EA; Cantor JP; Curcillo PG
J Am Coll Surg; 2005 Sep; 201(3):327-34. PubMed ID: 16125064
[TBL] [Abstract][Full Text] [Related]
19. Lymph nodes in the tail of the breast can be missed in standard axillary dissection.
Williams RN; Jones L; Stotter A
Eur J Surg Oncol; 2009 Mar; 35(3):271-5. PubMed ID: 18407454
[TBL] [Abstract][Full Text] [Related]
20. Octreotide in the treatment of lymphorrhea after axillary node dissection: a prospective randomized controlled trial.
Carcoforo P; Soliani G; Maestroni U; Donini A; Inderbitzin D; Hui TT; Lefor A; Avital I; Navarra G
J Am Coll Surg; 2003 Mar; 196(3):365-9. PubMed ID: 12648685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
